Abstract
Arboviruses are responsible for epidemics and are emerging and re-emerging in sub-Saharan Africa. However, the risk factors for arboviral diseases are poorly described in Kenyan children. Knowledge of risk factors can facilitate earlier diagnosis and better treatment and implementation of effective prevention in children.
This study determined risk factors for seropositivity to Yellow fever (YFV), Dengue (DENV), Chikungunya (CHIKV) and West Nile (WNV) viruses among children at two facilities in Teso Sub-County in Western Kenya.
In a hospital-based cross-sectional survey, the risk factors for seropositivity to the arboviruses were assessed. Eligible children aged 1 to 12 (n = 656) who visited Alupe Sub County Hospital and KEMRI Alupe Clinic in Teso Sub County were recruited. Socio-demographic, environmental, behavioural and medical information was collected using a questionnaire. Blood drawn from these children was screened for antibodies to YFV, DENV, CHIKV and WNV using Indirect Enzyme-Linked Immunosorbent Assays. Descriptive statistics were used to summarise seroprevalence, socio-demographic, clinical and environmental variables. Binomial logistic regression described the relationship between the risk factors and arbovirus seropositivity.
Seropositivity to at least one arbovirus was found in 27.7%, with 15.7% being positive for DENV, 9.6% for WNV, 5.6% for CHIKV and 4.4% for YFV.
The factors that significantly increased the risk to at least one of the arboviruses were: age 6-9 years (by 18%, p=0.006) compared to those 1-3 years, school attendance (by 66%, p=0.000) compared to none, the primary caregiver being “Other” (by 17%, p=0.026) and not the parent, the use of Olyset (by 7%, p=0.039), or an unknown mosquito net (by 26%, p=0.020) compared to Permanet.
The risk of yellow fever seropositivity was increased where vegetation was close to the house (by 5%, p=0.042) compared to where vegetation was far. The risk was decreased by the use of an unknown bed net (by 4%, p=0.046) compared to Permanet and having a past history of rash (by 6%, p=0.018).
For Dengue Fever, females were at an increased risk (by 8%, p=0.002) compared to males and having water bodies near the house (7%, p=0.030).
The risk of chikungunya was increased by school attendance (by 25%, p=0.021) compared to not, the use of mosquito repellents (by 10%, p=0.006) compared to no interventions and having had a rash in the past (by 6%, p=0.043). The risk was decreased by roofing with iron sheets (by 3%, p=0.048) compared to grass-thatching. WNV seropositivity risk was higher in those aged 3-6 years (by 8%, p=0.004) and 6-9 years (by 15%, p=0.004) than in those aged 1-3 years. It was increased in those attending school (by 37%, p=0.006) compared to those not, and those using Olyset (by 11%, p=0.000) or an unknown bed net (by 30%, p=0.001) compared to Permanet. The risk was lower by between 25% and 33% (p<0.003) in those in pre-school, in lower and upper primary compared to those not in school. These factors are amenable to interventions that can be implemented to prevent and reduce arbovirus infections in children in endemic areas in Kenya.
Author Summary Yellow fever, Dengue, Chikungunya and West Nile are viruses (Arboviruses) transmitted to humans by mosquitoes. These infections are common in Sub-Saharan Africa and often affect children. However, the risk factors associated with arboviral infections are not well described, and yet, knowledge of these predisposing factors in children is essential for early diagnosis, correct treatment, and prevention. We carried out this study to determine the factors associated with these infections. We recruited 656 children aged between 1-12 years who sought health services at Alupe Sub-County Hospital and KEMRI Alupe Clinic in Teso Sub-County, Western Kenya. We used a structured questionnaire to collect data on sociodemographic, behavioural, environmental, and clinical factors. We then drew blood from these children and screened it for the four arboviruses. Out of 656 participants, 182 (27.7%) were seropositive for at least one of the four arboviruses, 29 (4.4%) for Yellow Fever, 102 (15.7%) for Dengue, 36 (5.6%) for Chikungunya and 62 (9.6%) for West Nile virus. We established that gender, age, school attendance, the primary caregiver, design of the house, type of mosquito nets used, skin rashes and other mosquito control methods all influence the risk of seropositivity. These behavioural, environmental, sociodemographic and clinical factors that influence arbovirus seropositivity are amenable to interventions that can be implemented within the community to reduce the risk and prevalence of arboviruses in children in endemic areas in Kenya.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Department of Virology, Nagasaki University Institute of Tropical Medicine, Nagasaki, Japan and Kenya Medical Research Institute, Nairobi, Kenya.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Kenyatta National Hospital-University of Nairobi Ethics and Research Committee P.O Box 19676-00202 Nairobi Email: uonknh_erc@uonbi.ac.ke Telephone: 0799-495829 / 0799-495830
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Requests for data requests can be made to: The Director Kenya Medical Research Institute (KEMRI). Email: director{at}kemri.go.ke
